Replies to post #184936 on Biotech Values

[jbog]

And we all know that the cash surplus means nothing at this point. It's what they do with it that effects the equity in the long run. Now that they are backing away from the antibiotic field it'll be interesting what excites them.

[DewDiligence]

ENTA +10%—all-time intraday ($51.47) and closing ($51.31) highs.

[DewDiligence]

ENTA—New all-time intraday (51.99) and closing (51.61) highs. +11% this week.